| Study |
Reference |
|
Andersen (control exposed to PTU), 2019
|
Andersen Maternal thyroid function, use of antithyroid drugs in early pregnancy and birth defects. J. Clin. Endocrinol. Metab. 2019; :
|
|
Andersen (control unexposed, disease free), 2019
|
Andersen Maternal thyroid function, use of antithyroid drugs in early pregnancy and birth defects. J. Clin. Endocrinol. Metab. 2019; :
|
|
Andersen 2014 (control unexposed, disease free), 2014
|
Andersen Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole/carbimazole embryopathy. Eur J Endocrinol. 2014 Nov;171(5):C1-3. doi: 10.1530/EJE-14-0524. Epub 2014 Jul 28.
|
|
Andersen 2017 (control exposed to PTU), 2017
|
Andersen Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur. J. Endocrinol. 2017; 177:369-378
|
|
Andersen 2017 (control unexposed, disease free), 2017
|
Andersen Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur. J. Endocrinol. 2017; 177:369-378
|
|
Andersen 2017 (control unexposed, sick), 2017
|
Andersen Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur. J. Endocrinol. 2017; 177:369-378
|
|
Azizi, 2002
|
Azizi Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy J Endocrinol Invest. 2002;25(7):586-9.
|
|
Banhidy, 2011
|
Banhidy Possible association between hyperthyroidism in pregnant women and obstructive congenital abnormalities of urinary tract in their offspring--a population-based case-control study. J. Matern. Fetal. Neonatal. Med. 2011; 24:305-12
|
|
Barbero, 2008
|
Barbero Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am. J. Med. Genet. A 2008; 146A:2390-5
|
|
Chen (control exposed to PTU), 2011
|
Chen Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011; 118:1365-73
|
|
Chen (control unexposed, disease free), 2011
|
Chen Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011; 118:1365-73
|
|
Chen (control unexposed, sick), 2011
|
Chen Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011; 118:1365-73
|
|
Clementi, 2010
|
Clementi Treatment of hyperthyroidism in pregnancy and birth defects. J. Clin. Endocrinol. Metab. 2010; 95:E337-41
|
|
Di Gianantonio, 2001
|
Di Gianantonio Adverse effects of prenatal methimazole exposure. Teratology 2001; 64:262-6
|
|
Dwarakanath (control exposed to PTU), 1999
|
Dwarakanath Graves' Disease during pregnancy--results of antithyroid drug therapy. Singapore Med J 1999; 40:70-3
|
|
Gianetti (control exposed to PTU), 2015
|
Gianetti Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. J. Endocrinol. Invest. 2015; 38:977-85
|
|
Gianetti (control unexposed, sick), 2015
|
Gianetti Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. J. Endocrinol. Invest. 2015; 38:977-85
|
|
Hawken (control exposed to PTU), 2016
|
Hawken Management of Graves' disease during pregnancy in the Poitou-Charentes Region. Ann. Endocrinol. (Paris) 2016; 77:570-577
|
|
Khoury, 1989
|
Khoury Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study. Paediatr Perinat Epidemiol 1989; 3:402-20
|
|
Korelitz (control exposed to PTU), 2013
|
Korelitz Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013; 23:758-65
|
|
Korelitz (control unexposed, disease free), 2013
|
Korelitz Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013; 23:758-65
|
|
Korelitz (control unexposed, sick), 2013
|
Korelitz Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013; 23:758-65
|
|
Lo (control exposed to PTU), 2015
|
Lo Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid 2015; 25:698-705
|
|
Lo (control unexposed, sick), 2015
|
Lo Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid 2015; 25:698-705
|
|
McCarroll (Buckinghamshire control group), 1976
|
McCarroll Long-term assessment of children exposed in utero to carbimazole. Arch. Dis. Child. 1976; 51:532-6
|
|
McCarroll (Northern Ireland control group), 1976
|
McCarroll Long-term assessment of children exposed in utero to carbimazole. Arch. Dis. Child. 1976; 51:532-6
|
|
Momotani, 1984
|
Momotani Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf). 1984;20(6):695-700.
|
|
Momotani (control exposed to PTU), 1997
|
Momotani Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J. Clin. Endocrinol. Metab. 1997; 82:3633-6
|
|
Seo (control exposed to PTU), 2018
|
Seo Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study. Ann. Intern. Med. 2018; 168:405-413
|
|
Seo (control unexposed, NOS), 2018
|
Seo Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study. Ann. Intern. Med. 2018; 168:405-413
|
|
Wing (control exposed to PTU), 1994
|
Wing A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol. 1994; 170:90-5
|
|
Wing (control unexposed, sick), 1994
|
Wing A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol. 1994; 170:90-5
|
|
Yoshihara (control exposed to PTU), 2012
|
Yoshihara Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J. Clin. Endocrinol. Metab. 2012; 97:2396-403
|
|
Yoshihara (control unexposed, sick), 2012
|
Yoshihara Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J. Clin. Endocrinol. Metab. 2012; 97:2396-403
|
|
Yoshihara (Controls exposed to PTU), 2021
|
Yoshihara Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc 2021; 5:bvaa204
|
|
Yoshihara (Controls unexposed, sick), 2021
|
Yoshihara Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc 2021; 5:bvaa204
|
